Literature DB >> 209687

Dissection of a continuous distribution: red cell galactokinase activity in blacks.

R S Spielman, H Harris, W J Melliman, H Gershowitz.   

Abstract

A significant difference between blacks and whites in the distribution of red cell galactokinase (GALK) has been found by Tedesco et al. [2]. From the shapes of the distributions, it was inferred that whites are essentially all homozygous for one allele (GALKA), but blacks are polymorphic. A second allele (GALKP), for lower GALK activity, is presented at high frequency in blacks but rare or absent in whites. This paper presents a method which, assuming the genetic model presented, estimates the genotype composition of the black sample. We make some reasonable biochemical assumptions and fit a mixture of three normal distributions to the black data to obtain an estimate of p, the frequency of GALKA in blacks. The fit of the model to the data is excellent and the best estimate of p is .217 +/- .025. Since admixture of white genes in blacks from the United States is known to be about 20%, the value of p implies that virtually all GALKA alleles were introduced by admixture, and that the ancestral black population was monomorphic for GALKP. If whites are indeed monomorphic for GALKA, they differ from unmixed blacks by a full gene substitution at the locus for GALK.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 209687      PMCID: PMC1685577     

Source DB:  PubMed          Journal:  Am J Hum Genet        ISSN: 0002-9297            Impact factor:   11.025


  10 in total

1.  QUANTITATIVE DIFFERENCES AND GENE DOSAGE IN THE HUMAN RED CELL ACID PHOSPHATASE POLYMORPHISM.

Authors:  N SPENCER; D A HOPKINSON; H HARRIS
Journal:  Nature       Date:  1964-01-18       Impact factor: 49.962

2.  The pseudocholinesterase variants. Esterase levels and dibucaine numbers in families selected through suxamethonium sensitive individuals.

Authors:  H HARRIS; M WHITTAKER; H LEHMANN; E SILK
Journal:  Acta Genet Stat Med       Date:  1960

3.  Common polymorphism of peptidase A. Electrohoretic variants associated with quantitative variation of red cell levels.

Authors:  W H Lewis
Journal:  Ann Hum Genet       Date:  1973-01       Impact factor: 1.670

4.  Quantitative genetics of human red cell acid phosphatase.

Authors:  L C Eze; M C Tweedie; M F Bullen; P J Wren; D A Evans
Journal:  Ann Hum Genet       Date:  1974-01       Impact factor: 1.670

5.  Genetics of glutamic-pyruvic transaminase: its inheritance, common and rare variants, population distribution, and differences in catalytic activity.

Authors:  S H Chen; E R Giblett; J E Anderson; B L Fossum
Journal:  Ann Hum Genet       Date:  1972-04       Impact factor: 1.670

6.  A general model for the genetic analysis of pedigree data.

Authors:  R C Elston; J Stewart
Journal:  Hum Hered       Date:  1971       Impact factor: 0.444

Review 7.  Caucasian genes in American Negroes.

Authors:  T E Reed
Journal:  Science       Date:  1969-08-22       Impact factor: 47.728

8.  Population genetics of the human allotypes Gm, Inv, and A2m.

Authors:  W E Johnson; P H Kohn; A G Steinberg
Journal:  Clin Immunol Immunopathol       Date:  1977-01

9.  Human erythrocyte galactokinase and galactose-1-phosphate uridylyltransferase: a population survey.

Authors:  T A Tedesco; K L Miller; B E Rawnsley; M T Mennuti; R S Spielman; W J Mellman
Journal:  Am J Hum Genet       Date:  1975-11       Impact factor: 11.025

10.  Galactokinase: evidence for a new racial polymorphism.

Authors:  T A Tedesco; R Bonow; K Miller; W J Mellman
Journal:  Science       Date:  1972-10-13       Impact factor: 47.728

  10 in total
  2 in total

1.  Simple test statistics for major gene detection: a numerical comparison.

Authors:  P Le Roy; J M Elsen
Journal:  Theor Appl Genet       Date:  1992-03       Impact factor: 5.699

2.  Screening of the Philadelphia variant of galactokinase in racially unmixed black Africans: first results.

Authors:  T Soni; M Brivet; M Blanc; G Jaeger; A Lemonnier
Journal:  Am J Hum Genet       Date:  1988-01       Impact factor: 11.025

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.